Stockscreener 앱 받기
16.98
0.18%
-0.03
시간 외 거래:
16.98
전일 마감가:
$17.01
열려 있는:
$17.01
하루 거래량:
14,524
Relative Volume:
0.28
시가총액:
$712.23M
수익:
-
순이익/손실:
$-75.28M
주가수익비율:
-11.96
EPS:
-1.42
순현금흐름:
$-57.45M
1주 성능:
-0.64%
1개월 성능:
+13.88%
6개월 성능:
+45.13%
1년 성능:
+57.22%
1일 변동 폭
$16.98
$17.05
1주일 범위
$16.98
$17.55
52주 변동 폭
$10.11
$18.00
Oculis Holding Ag Stock (OCS) Company Profile
OCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OCS
Oculis Holding Ag
|
16.98 | 712.23M | 0 | -75.28M | -57.45M | -1.9957 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-05 | 개시 | Chardan Capital Markets | Buy |
| 2023-10-05 | 개시 | Stifel | Buy |
| 2023-06-14 | 개시 | BofA Securities | Buy |
| 2023-06-12 | 개시 | H.C. Wainwright | Buy |
| 2023-06-08 | 개시 | Robert W. Baird | Outperform |
| 2023-05-10 | 개시 | Pareto | Buy |
| 2023-04-28 | 개시 | Wedbush | Outperform |
모두보기
Oculis Holding Ag 주식(OCS)의 최신 뉴스
(OCS) Investment Analysis and Advice - Stock Traders Daily
Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume – Here’s Why - Defense World
Oculis (NASDAQ:OCS) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
(OCS) Investment Report - Stock Traders Daily
Oculis Directors Complete RSU Vesting Transaction in Strategic Stock Move - StockTitan
Oculis Holding AG (NASDAQ:OCS) Short Interest Update - MarketBeat
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated - Marketscreener.com
Oculis Announces Major Share Vesting Event for Key Executives | OCS Stock News - StockTitan
Where are the Opportunities in (OCS) - Stock Traders Daily
Oculis Publishes Notification of Transaction by Person Discharging Managerial Responsibilities - Marketscreener.com
Oculis Awards Equity Incentive to Director Arshad Khanani for Consulting Services | OCS Stock News - StockTitan
Oculis (NASDAQ:OCS) Shares Up 3.8%Here's Why - MarketBeat
(OCS) Investment Analysis - Stock Traders Daily
Is Oculis Holding (OCS) Top Performing European Stock Heading into 2025? - Insider Monkey
Oculis to Present at the Stifel 2024 Healthcare Conference - The Manila Times
Oculis (OCS) to Present at Stifel Healthcare Conference: CFO Fireside Chat Announced | OCS Stock News - StockTitan
10 Top Performing European Stocks Heading into 2025 - Insider Monkey
HC Wainwright Reiterates Buy Rating for Oculis (NASDAQ:OCS) - MarketBeat
Oculis Holding AG Reports Q3 2024 Financial Progress - TipRanks
Oculis Holding’s Financial Struggles Amid Asset Growth - TipRanks
Oculis Holding AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Oculis Reports Q3 2024 Financial Results and Provides Company Updates - GlobeNewswire
Oculis birtir uppgjör fyrir þriðja ársfjórðung 2024 og kynnir nýjustu áfanga í rekstri félagsins - GlobeNewswire Inc.
Oculis (OCS) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Oculis (NASDAQ:OCS) Hits New 12-Month HighWhat's Next? - MarketBeat
Oculis: Lack Of Coverage Only Real Risk For This Solid Company - Seeking Alpha
abrdn plc Sells 279,879 Shares of Oculis Holding AG (NASDAQ:OCS) - MarketBeat
Oculis (NASDAQ:OCS) Sees Strong Trading VolumeHere's Why - MarketBeat
Oculis Holding AG (OCS) Moves 7.9% Higher: Will This Strength Last? - MSN
Oculis Holding AG's (NASDAQ:OCS) largest shareholders are individual investors with 56% ownership, institutions own 39% - Yahoo Finance
Oculis (NASDAQ:OCS) Reaches New 1-Year HighStill a Buy? - MarketBeat
Short Interest in Oculis Holding AG (NASDAQ:OCS) Grows By 133.7% - MarketBeat
Trading (OCS) With Integrated Risk Controls - Stock Traders Daily
Oculis (NASDAQ:OCS) Shares Gap DownHere's Why - MarketBeat
Oculis (NASDAQ:OCS) Shares Gap UpHere's Why - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Oculis (NASDAQ:OCS) - MarketBeat
Financial Comparison: Oculis (NASDAQ:OCS) and Terns Pharmaceuticals (NASDAQ:TERN) - Defense World
Oculis (NASDAQ:OCS) Reaches New 52-Week HighTime to Buy? - MarketBeat
Oculis Holding AG's (NASDAQ:OCS) market cap touched US$586m last week, benefiting both individual investors who own 55% as well as institutions - Simply Wall St
Oculis accelerates patient enrollment for both Phase 3 DIAMOND trials - TipRanks
Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees - StockTitan
Oculis (NASDAQ:OCS) Trading Up 4.8%Here's What Happened - MarketBeat
Oculis Accelerates Enrollment in both DIAMOND Phase 3 - GlobeNewswire
OCSOculis Holding AG Ordinary shares Latest Stock News & Market Updates - StockTitan
Oculis Holding Ag (OCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):